Companies / Bellevue Life Sciences Acquisition Corp.
Bellevue Life Sciences Acquisition Corp.
BLACOSRHCIK 1840425
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 14, 2023 | Bellevue Capital Management LLC 10% owner | Grant Grant or award | Common Stock | $4.30M | +430K +31.39% | 1,800,000 | low |
| Feb 14, 2023 | Hwang Kuk Hyoun CEO | Grant Grant or award | Common Stock | $4.30M | +430K +31.39% | 1,800,000 | low |
| Feb 14, 2025 | Bellevue Capital Management LLC 10% owner | Other Other (per filing) | Common Stock | $0 | +43K +2.15% | 2,043,500 | low |
| Feb 14, 2025 | Hwang Kuk Hyoun CEO | Other Other (per filing) | Common Stock | $0 | +3.1M +32.63% | 12,699,104 | low |
| Feb 14, 2025 | Hwang Kuk Hyoun CEO | Other Other (per filing) | Common Stock | $0 | +7.5M +368.57% | 9,575,134 | low |
| Feb 14, 2025 | Hwang Kuk Hyoun CEO | Other Other (per filing) | Common Stock | $0 | +43K +2.15% | 2,043,500 | low |
| Mar 23, 2023 | Hwang Kuk Hyoun CEO | Other Other (per filing) | Common Stock | $0 | -20K -0.99% | 2,000,500 | low |
| Mar 23, 2023 | Yoo David Jin Executive | Grant Grant or award | Common Stock | $0 | +20K | 20,000 | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| BLAC | common | 079174108 |
| BLAC | common | 68840D102 |